The roles of the CB1 and CB2 cannabinoid receptors in the anti-inflammatory outcomes of JZL184 ended up subsequent analyzed making use of AM281 (a CB1 receptor antagonist) and AM630 (a CB2 receptor antagonist) as pharmacological tools
The knowledge confirmed that the AM281 and AM630 remedies partly abrogated the JZL184induced steps...